Knowstox

Fundamentals snapshot

The Clorox Company

CLX · NYQ · Consumer Defensive · Household & Personal Products

Current price

$95.80

52-week range

$84.70 - $132.03

Market cap

$11.58B

One-glance verdict

Undervalued

$110.59 our estimate vs market $95.80

Wall Street consensus: $105.29 (-4.8% lower than our fair-value estimate)

Balance sheet

Distressed

13.38x Strong cushion

Net debt $3.29B. Interest coverage shows how many times profit covers the interest bill.

What this company does

The Clorox Company

Clorox is the company behind many household staples you'd find in a supermarket, such as Clorox bleach, Glad bags, Kingsford charcoal, and Burt's Bees lip balm. The company makes most of its money selling these everyday products that people buy over and over again through major retailers like Walmart and grocery stores. Because customers often need to repurchase these items regardless of the economy, the company's sales can be more stable than businesses that sell optional or luxury goods.

Price history

How the share price has moved

Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q4 $259.00M FY2025 Q1 $182.00M FY2025 Q2 $127.00M FY2025 Q3 $233.00M FY2025 Q4 $219.00M FY2026 Q1 $57.00M FY2026 Q2 $269.00M FY2026 Q3 $-165.00M
Revenue $1.67B
Net income $187.00M
Diluted EPS 1.54
Operating cash flow $-122.00M
Free cash flow $-165.00M
Revenue $1.67B
Net income $157.00M
Diluted EPS 1.29
Operating cash flow $311.00M
Free cash flow $269.00M
Revenue $1.43B
Net income $80.00M
Diluted EPS 0.65
Operating cash flow $93.00M
Free cash flow $57.00M
Revenue $1.99B
Net income $332.00M
Diluted EPS 2.68
Operating cash flow $294.00M
Free cash flow $219.00M
Revenue $1.67B
Net income $186.00M
Diluted EPS 1.50
Operating cash flow $286.00M
Free cash flow $233.00M
Revenue $1.69B
Net income $193.00M
Diluted EPS 1.54
Operating cash flow $180.00M
Free cash flow $127.00M
Revenue $1.76B
Net income $99.00M
Diluted EPS 0.80
Operating cash flow $221.00M
Free cash flow $182.00M
Revenue $1.90B
Net income $216.00M
Diluted EPS 1.74
Operating cash flow $340.00M
Free cash flow $259.00M

Is it cheap or expensive?

Fair value $110.59 vs current price $95.80

Wall Street consensus is the average analyst price target: $105.29 (-4.8% lower than our fair-value estimate).

Our most-likely fair value is $110.59 a share — about 15.4% above today's price of $95.80, so the stock currently looks cheap (undervalued).

undervalued

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 2.5% · Discount 7.2% · Terminal 2.5%

$110.59

Bear

Growth 2.5% · Discount 7.2% · Terminal 2.5%

$110.59

Bull

Growth 4.0% · Discount 7.2% · Terminal 2.5%

$123.45

Is it drowning in debt?

Distressed

Net debt $3.3B. Interest coverage 13.4x.

Net debt $3.29B
Interest coverage 13.38x

The Clorox Company's profit covers its interest bill about 13.4 times over. which is stronger than most peers shown here.

Distressed
Worse cushion Baseline Better cushion
CLX BASELINE The Clorox Company

Total debt $4.49B Interest coverage 13.38x This is the baseline the peer rows are being compared against.

Total debt $37.03B Interest coverage 22.55x +69% vs CLX Carries about 1.7x more debt cushion than CLX.

Total debt $7.11B Interest coverage 9.18x -31% vs CLX Carries about 1.5x less debt cushion than CLX.

Total debt $7.97B Interest coverage 15.85x +19% vs CLX Carries about 1.2x more debt cushion than CLX.

Total debt $2.38B Interest coverage 11.32x -15% vs CLX Carries about 1.2x less debt cushion than CLX.

Total debt $32.40B Interest coverage 9.22x -31% vs CLX Carries about 1.5x less debt cushion than CLX.

What you should know

The case for and against CLX

3 Rewards 0 Risks

Rewards

  • Returns 546.1% on equity, ahead of 83% of its peers.
  • Free cash flow was positive in 10/10 years.
  • Trades at 15.6x P/E vs peer median 22.0x (29.1% cheaper).

Risks

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
15.58x
Forward P/E
15.30x
P/B
-172.92x
P/S
1.71x
EV/EBITDA
11.80x
PEG ratio
2.17x

Profitability

How much profit each dollar creates

Gross margin
43.8%
Operating margin
17.0%
Net margin
11.2%
ROE
546.1%
ROA
11.0%

Health

Liquidity and balance-sheet strength

Debt / equity
48.76x
Current ratio
0.84x
Quick ratio
0.59x
Total debt
$4.49B
Total cash
$1.19B

Growth

How the business has been compounding

Revenue TTM
$6.76B
Revenue 5Y CAGR
-0.8%
EPS TTM
6.15
EPS 5Y CAGR
-26.1%

Cash flow

How much cash the business throws off

Operating CF TTM
$576.00M
Free CF TTM
$761.00M
FCF margin
11.3%

Dividend

Shareholder payout

Yield
5.2%
Payout ratio
80.3%
Last ex-div date
2026-04-22